The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Anti-Inflammatory Agents for Cancer Therapy
Open accessAbstract
Inflammation is closely linked to cancer, and many anti-cancer agents are also used to treat inflammatory diseases, such as rheumatoid arthritis. Moreover, chronic inflammation increases the risk for various cancers, indicating that eliminating inflammation may represent a valid strategy for cancer prevention and therapy. This article explores the relationship between inflammation and cancer with an emphasis on epidemiological evidence, summarizes the current use of anti-inflammatory agents for cancer prevention and therapy, and describes the mechanisms underlying the anti-cancer effects of anti-inflammatory agents. Since monotherapy is generally insufficient for treating cancer, the combined use of anti-inflammatory agents and conventional cancer therapy is also a focal point in discussion. In addition, we also briefly describe future directions that should be explored for anti-cancer anti-inflammatory agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Rw, A., Akovbiantz, A., Largiadèr, F., et al. (1984) · PubMed · Cited by 707
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials
Strimpakos, A. S., & Sharma, R. A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1769 · Cited by 645
Sulindac for polyposis of the colon
Waddell, W. R., & Loughry, R. W. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930240119 · Cited by 513
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G. L., Loar, A., Rodabough, R. J., White, E., & McTiernan, A. (2003) · PubMed · Cited by 411
Sulindac for polyposis of the colon
Waddell, W. R., Ganser, G. F., Cerise, E. J., & Loughry, R. W. (1989) · The American Journal of Surgery · doi:10.1016/0002-9610(89)90442-x · Cited by 409
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
NELSON, W. G., DE MARZO, A. M., DeWEESE, T. L., & ISAACS, W. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142058.99614.ff · Cited by 386
Anti-Inflammatory Responses of Resveratrol
Das, S., & Das, D. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807781696464 · Cited by 382
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., & Seegert, D. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.613 · Cited by 360
Molecular mechanisms of aging-associated inflammation
Sarkar, D., & Fisher, P. B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.009 · Cited by 359
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Kune, G. A., Kune, S., & Watson, L. F. (1988) · PubMed · Cited by 352
Oestrogen receptor negative breast cancers exhibit high cytokine content
Chavey, C., Bibeau, F., Gourgou-Bourgade, S., Burlinchon, S., Boissière, F., Laune, D., Roques, S., & Lazennec, G. (2007) · Breast Cancer Research · doi:10.1186/bcr1648 · Cited by 349
Granulomatous inflammation--a review.
Williams, G. T., & Williams, W. J. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.7.723 · Cited by 329
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Van Waes, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 292
Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., & Hori, M. (1999) · PubMed · Cited by 270
Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
Cruz–Correa, M., Hylind, L. M., Romans, K. E., Booker, S. V., & Giardiello, F. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.31890 · Cited by 245
Role of curcumin in health and disease
Pari, L., Tewas, D., & Eckel, J. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802033958 · Cited by 245
Lu, Y., Cai, Z., Galson, D. L., Xiao, G., Liu, Y., George, D. E., Melhem, M. F., Yao, Z., & Zhang, J. (2006) · The Prostate · doi:10.1002/pros.20464 · Cited by 242
The role of COX-2 inhibition in breast cancer treatment and prevention
Arun, B., & Goss, P. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.042 · Cited by 235
Inflammation, Cancer, and Targets of Ginseng
Hofseth, L. J., & Wargovich, M. J. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.183s · Cited by 207
Tumor Inflammatory Angiogenesis and Its Chemoprevention
Albini, A., Tosetti, F., Benelli, R., & Noonan, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3473 · Cited by 194
Stark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0529fje · Cited by 191
Candelario-Jalil, E., Taheri, S., Yang, Y., Sood, R., Grossetete, M., Estrada, E. Y., Fiebich, B. L., & Rosenberg, G. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127035 · Cited by 189
Adverse drug interactions involving common prescription and over-the-counter analgesic agents
Hersh, E. V., Pinto, A., & Moore, P. A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.003 · Cited by 182
Gong, H., Jarzynka, M. J., Cole, T. J., Lee, J. H., Wada, T., Zhang, B., Gao, J., Song, W., DeFranco, D. B., Cheng, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1545 · Cited by 178
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
de Groot, D. J. A., de Vries, E. G. E., Groen, H. J. M., & de Jong, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.001 · Cited by 175
Gridelli, C., Gallo, C., Ceribelli, A., Gebbia, V., Gamucci, T., Ciardiello, F., Carozza, F., Favaretto, A. G., Daniele, B., Galetta, D., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70146-8 · Cited by 169
Inflammatory Mechanisms Contributing to Pancreatic Cancer Development
Farrow, B., Sugiyama, Y., Chen, A., Uffort, E., Nealon, W., & Mark Evers, B. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128681.76786.07 · Cited by 168
Sassano, A., & Platanias, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.036 · Cited by 168
Involvement of Chemokine Receptors in Organ-Specific Metastasis
Zlotnik, A. (2006) · Contributions to Microbiology · doi:10.1159/000092973 · Cited by 159
Jana, N. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7511-x · Cited by 159
The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones.
Belman, S., & Troll, W. (1972) · PubMed · Cited by 154
Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer Cells
Yano, A., Fujii, Y., Iwai, A., Kageyama, Y., & Kihara, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2085 · Cited by 148
Toll-like receptors expressed in tumor cells: targets for therapy
Yu, L., & Chen, S. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0459-8 · Cited by 147
Aspirin Induces Apoptosis through the Inhibition of Proteasome Function
Dikshit, P., Chatterjee, M., Goswami, A., Mishra, A., & Jana, N. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602629200 · Cited by 145
Sung, B., Jhurani, S., Ahn, K. S., Mastuo, Y., Yi, T., Guha, S., Liu, M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2155 · Cited by 140
Shirin, H., Pinto, J. T., Kawabata, Y., Soh, J. W., Delohery, T. M., Moss, S. F., Murty, V. V. V. S., Rivlin, R. S., Holt, P. R., & Weinstein, I. B. (2001) · PubMed · Cited by 140
Kim, S., Lee, J. M., Park, J. S., Jo, S. A., Kim, Y., Kim, C., & Jo, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.025 · Cited by 137
Kashfi, K., Rayyan, Y. M., QIAO, L., Williams, J. L., Chen, J., Soldato, P. D., Traganos, F., & Rigas, B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042754 · Cited by 134
Wang, H., Li, M., Rinehart, J. J., & Zhang, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0829-3 · Cited by 130
Epidemiology and Risk Factors for Colorectal Dysplasia and Cancer in Ulcerative Colitis
Loftus, E. V. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2006.07.005 · Cited by 129
Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems
Otsuki, M. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300058 · Cited by 123
Therapy Insight: potential of statins for cancer chemoprevention and therapy
Katz, M. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0097 · Cited by 123
Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment
Lee, J. M., Yanagawa, J., Peebles, K. A., Sharma, S. P., Mao, J. T., & Dubinett, S. M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.004 · Cited by 120
Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer
Gu, Q., Wang, J. D., Xia, H. H., Lin, M. C.-M., He, H., Zou, B., Tu, S. P., Yang, Y., Liu, X., Lam, S. K., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh345 · Cited by 115
Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy
Schönthal, A. H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604049 · Cited by 112
Dandekar, D. S., Lopez, M. H., Carey, R. I., & Lokeshwar, B. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.20878 · Cited by 105
Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy
Hassan, H. T. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.008 · Cited by 101
Schönthal, A. H., Chen, T. C., Hofman, F. M., Louie, S. G., & Petasis, N. A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.197 · Cited by 95
Nakata, E., Mason, K. A., Hunter, N. R., Husain, A., Raju, U., Liao, Z. X., Ang, K. K., & Milas, L. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.061 · Cited by 94
Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
Xiao, H., & Yang, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23718 · Cited by 92
Wang, H., Wang, Y., Rayburn, E. R., Hill, D. L., Rinehart, J. J., & Zhang, R. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.947 · Cited by 88
Self-citationFecker, L. F., Stockfleth, E., Nindl, I., Ulrich, C., Forschner, T., & Eberle, J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07856.x · Cited by 88
Bardia, A., Ebbert, J. O., Vierkant, R. A., Limburg, P. J., Anderson, K., Wang, A. H., Olson, J. E., Vachon, C., & Cerhan, J. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk200 · Cited by 86
Clinical investigations of Toll-like receptor agonists
Meyer, T., & Stockfleth, E. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.1051 · Cited by 82
Bandarage, U. K., Chen, L., Fang, X., Garvey, D. S., Glavin, A., Janero, D. R., Letts, L. G., Mercer, G. J., Saha, J. K., Schroeder, J. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000178w · Cited by 81
Identifying and defusing weapons of mass inflammation in carcinogenesis
Hofseth, L. J., & Ying, L. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.005 · Cited by 80
Pan, M., Chang, H., & Hung, W. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.004 · Cited by 80
Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.
Kristjansen, P. E. G., Boucher, Y., & Jain, R. K. (1993) · PubMed · Cited by 76
van Wijngaarden, J., van Beek, E. R., van Rossum, G., van der Bent, C., Hoekman, K., van der Pluijm, G., van der Pol, M. A., Broxterman, H. J., van Hinsbergh, V. W. M., & Löwik, C. W. G. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.010 · Cited by 75
Dittmann, K., Mayer, C., Ohneseit, P., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.065 · Cited by 75
Chuang, H.-C., Kardosh, A., Gaffney, K. J., Petasis, N. A., & Schönthal, A. H. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-38 · Cited by 74
Advances in anti-emetic therapy
Bakowski, M. T. (1984) · Cancer Treatment Reviews · doi:10.1016/0305-7372(84)90010-0 · Cited by 72
Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782794194 · Cited by 70
Celecoxib and Curcumin Additively Inhibit the Growth of Colorectal Cancer in a Rat Model
Shpitz, B., Giladi, N., Sagiv, E., et al. (2006) · Digestion · doi:10.1159/000098655 · Cited by 70
Novel Therapeutic Targets In Bladder Cancer: Mutation and Expression of Fgf Receptors
Knowles, M. A. (2008) · Future Oncology · doi:10.2217/14796694.4.1.71 · Cited by 69
Ponthan, F., Wickström, M., Gleissman, H., Fuskevåg, O., Segerström, L., Sveinbjørnsson, B., Redfern, C. P. F., Eksborg, S., Kogner, P., & Johnsen, J. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1908 · Cited by 67
NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action
Rigas, B., & Williams, J. L. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.022 · Cited by 64
O'Connor, R. A., O’Leary, M., Ballot, J., Collins, C. D., Kinsella, P., Mager, D. E., Arnold, R. D., O’Driscoll, L., Larkin, A., Kennedy, S., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0240-7 · Cited by 62
Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
Fleming, M. T., Morris, M. J., Heller, G., & Scher, H. I. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0664 · Cited by 61
Sulindac suppresses β-catenin expression in human cancer cells
Han, A., Song, Z., Tong, C., Hu, D. G., Bi, X., Augenlicht, L. H., & Yang, W. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.034 · Cited by 61
Colorectal cancer prevention: Is an ounce of prevention worth a pound of cure?
Gill, S., & Sinicrope, F. A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.038 · Cited by 61
Herrera, F. G., Chan, P., Doll, C., Milosevic, M., Oza, A. M., Syed, A., Pintilie, M., Levin, W., Manchul, L., & Fyles, A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.024 · Cited by 60
The anti-proliferative potency of celecoxib is not a class effect of coxibs
Schiffmann, S., Maier, T. J., Wobst, I., Janssen, A., Corban-Wilhelm, H., Angioni, C., Geißlinger, G., & Grösch, S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.04.017 · Cited by 56
Cyclooxygenase Inhibitors Down Regulate P-glycoprotein in Human Colorectal Caco-2 Cell Line
Zrieki, A., Farinotti, R., & Buyse, M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9596-1 · Cited by 55
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
Zhang, S. M., Cook, N. R., Manson, J. E., Lee, I.-M. M., & Buring, J. E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604240 · Cited by 55
Loveridge, C. J., MacDonald, A. D., Thoms, H. C., Dunlop, M. G., & Stark, L. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210891 · Cited by 52
Karthaus, M., Balló, H., Abenhardt, W., Steinmetz, T., Geer, T., Schimke, J., Braumann, D., Behrens, R., Behringer, D. M., Kindler, M., et al. (2005) · Oncology · doi:10.1159/000086971 · Cited by 49
Karjalainen, M. J., Neuvonen, P. J., & Backman, J. T. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00252.x · Cited by 47
Cancer cell: using inflammation to invade the host
Arias, J. I., Aller, M., & Árias, J. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-29 · Cited by 46
Javle, M. M., Cao, S., Durrani, F. A., Pendyala, L., Lawrence, D. D., Smith, P. F., Creaven, P. J., Noel, D., Iyer, R. V., & Rustum, Y. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0551 · Cited by 43
Casanova, I., Parreño, M., Farré, L., Guerrero, S., Céspedes, M. V., Pavón, M. Á., Sancho, F. J., Marcuello, E., Trías, M., & Mangues, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21662 · Cited by 42
Wang, H., Li, M., Rinehart, J. J., & Zhang, R. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0759-9 · Cited by 42
Fabi, A., Metro, G., Papaldo, P., Mottolese, M., Melucci, E., Carlini, P., Sperduti, I., Russillo, M., Gelibter, A. J., Ferretti, G., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0650-1 · Cited by 38
Howard, E. W., Lee, D. T., Chiu, Y. T., Chua, C. W., Wang, X., & Wong, Y. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23355 · Cited by 36
Farley, J. H., Truong, V., Goo, E. D. H., UYEHARA, C. F. T., Belnap, C., & Larsen, W. I. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.036 · Cited by 34
Immunotherapy for renal cell cancer in the era of targeted therapy
Coppin, C. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.6.907 · Cited by 34
Raju, B., Haug, S. R., Ibrahim, S. O., & Heyeraas, K. J. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00602.x · Cited by 33
Leggas, M. L., Kuo, K., Robert, F., Cloud, G., deShazo, M., Zhang, R., Li, M., Wang, H., Davidson, S., & Rinehart, J. J. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0767-x · Cited by 29
Gradilone, A., Pulcinelli, F. M., Lotti, L. V., Trifirò, E., Martino, S., Gandini, O., Gianni, W., Frati, L., Aglianò, A. M., & Gazzaniga, P. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133178 · Cited by 29
Castro‐Caldas, M., Mendes, A. F., Duarte, C. B., & Lopes, M. C. (2003) · Mediators of Inflammation · doi:10.1080/09629350310001633351 · Cited by 25
Compositions for Treatment of Cancer and Inflammation
Arber, N., Lev‐Ari, S., & Lichtenberg, D. A. (2008) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489208783478720 · Cited by 18
Cancers of the large bowel.Associated disorders in individuals
Adelstein, P., Baldwin, J. A., & Fedrich, J. (1979) · Cancer · Cited by 17
Cited by
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Inflammation-induced DNA damage, mutations and cancer
Kay, J., Thadhani, E., Samson, L., & Engelward, B. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102673 · Cited by 464
Anti-Inflammatory Drugs as Anticancer Agents
Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072605 · Cited by 395
Targeting Inflammation in Cancer Prevention and Therapy
Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 354
Cordycepin: A bioactive metabolite with therapeutic potential
Tuli, H. S., Sharma, A. K., Sandhu, S. S., & Kashyap, D. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.030 · Cited by 323
Metadata
- Authors
- Rayburn, E.
- Venue
- Molecular and Cellular Pharmacology
- Publisher
- Lumitext Publishing
- Published
- 2009-02-10
- Volume
- 1
- Issue
- 1
- Pages
- 29-43
- ISSN
- 1938-1247 (ISSN-L)
- OpenAlex
- W2094156804
- Cited by
- 341
- References
- 100
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.